Post-hoc analysis found that, despite continued titration with insulin glargine, more diabetes patients achieved sustained glycemic control with exenatide once-weekly. » Read the 3-year data from the DURATION-3 trial
Study offers further evidence of the long-term glycemic durability of dapagliflozin added to metformin in adult patients with type 2 diabetes who are unable to achieve glycemic control on metformin alone. » Four-year data from a phase 3 study explains more
#icymi
Editorial Questions? Contact the Editorial Team. Click Here.
Sales, Reprints, Classified questions? Contact the Sales Team. Click Here.
